A Study of Nivolumab in Selected Uterine Cancer Patients
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of nivolumab and find out what affects, if
any, nivolumab has on people and their risk of gynecologic cancer. The investigators also
want to find out what effects, good or bad, nivolumab has on the patient and their cancer.